Clinical trials
Recruiting Observational Dementia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
108 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 11 |
| 2022 | 14 |
| 2023 | 17 |
| 2024 | 13 |
| 2025 | 18 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 108 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Southern California | 3 |
| Xuanwu Hospital, Beijing | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Imperial College London | 2 |
| Johns Hopkins University | 2 |
| Longevity Metrics, Inc. | 2 |
| National Taiwan University Hospital | 2 |
| Ruijin Hospital | 2 |
| Tammie L. S. Benzinger, MD, PhD | 2 |
| Universitätsklinikum Hamburg-Eppendorf | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 108 |
| Alzheimer Disease | 58 |
| Cognitive Dysfunction | 52 |
| Dementia, Vascular | 11 |
| Neurodegenerative Diseases | 11 |
| Lewy Body Disease | 10 |
| Stroke | 9 |
| Neurocognitive Disorders | 7 |
| Parkinson Disease | 7 |
| Brain Diseases | 6 |
Trials
Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.
8 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.